Alemtuzumab is sold as Campath in the United
States. Alemtuzumab is a humanized monoclonal antibody that selectively binds
to CD52, a protein found on the surface of normal and malignant B and T cells,
that is used to reduce the numbers of circulating malignant cells of patients
who have B-cell chronic lymphocytic leukemia (B-CLL).
No comments:
Post a Comment